Viatris submitted two drug applications to the FDA that were generics for three of Merck’s type 2 diabetes drugs that have exclusivity until Nov. 24, 2026, Merck said in a Sept. 22 news release. The second patent, which is for its diabetes drug Janumet, is set to expire in 2029.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
